Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (year values) |
||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | |||
| EV/EBITDA | ? | 0.80 | 0.36 | 1.13 | -11.8 | -7.79 | -5.35 | |
| Changes by years, y/y, % | -55% | +211% | -1 148% | -34% | ||||
Constellation Pharmaceuticals. EV/EBITDA
Constellation Pharmaceuticals. EV/EBITDA, changes, %
Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2020Q1 | FY2020Q2 | FY2020Q3 | FY2020Q4 | FY2021Q1 | LTM ? | |||
| EV/EBITDA | ? | -11.2 | -8.19 | -4.64 | -7.75 | -5.35 | -5.35 | |
| Changes by years, y/y, % | -898% | -902% | +235% | -60% | -52% | |||
| Changes by quarters, q/q, % | -43% | -27% | -43% | +67% | -31% | |||